Journal Article
Review
Add like
Add dislike
Add to saved papers

Does non-malignant hypertension cause renal insufficiency? Evidence-based perspective.

While it is clear that malignant hypertension damages the kidneys, the question of whether non-malignant hypertension actually causes renal insufficiency remains controversial. A recent meta-analysis of 10 randomized controlled trials of antihypertensive drug therapy showed that patients randomized to antihypertensive therapy (or more-intensive therapy) did not show a significant reduction in their risk of developing renal dysfunction (relative risk, 0.97; 95% confidence interval, 0.78-1.21; P=0.77). A review of the totality of the evidence shows that there is relatively weak support for the thesis that non-malignant hypertension itself is an important de-novo cause (initiator) of renal insufficiency (as opposed to being a promoter of existing renal disease, which is a well established fact). Failure to evaluate the possibility that pre-existing renal disease could explain any observed association between elevated blood pressure and subsequent loss of renal function is an important limitation of published studies.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app